Latest Breaking News On - புற்றுநோய் ரெஸ் - Page 3 : comparemela.com

Aspirin and cancer survival: a systematic review and meta-analyses of 118 observational studies of aspirin and 18 cancers

Aspirin and cancer survival: a systematic review and meta-analyses of 118 observational studies of aspirin and 18 cancers
ecancer.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ecancer.org Daily Mail and Mail on Sunday newspapers.

South-korea
Ottawa
Ontario
Canada
United-kingdom
Taiwan
United-states
Denmark
Tumori
Cheju-do
Langley
Northumberland

Underdosing in Patients With Cancer and Obesity: A Thing of the Past?

Underdosing in Patients With Cancer and Obesity: A Thing of the Past?
renalandurologynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from renalandurologynews.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Memorial-sloan-kettering-cancer-center
New-hyde-park
Washington
American
Wasifm-saif
Neilm-iyengar
Gary-lyman
American-society-of-clinical-oncology
Rutgers-cancer-institute-of-new-jersey
Drug-administration

New Tech Provides Early Prediction of Chemotherapy Effectiveness

Researchers have discovered that by combining data from tumor biomarkers, ultrasound and ultrasound-guided diffuse optical tomography (DOT) after a patient's first cycle of chemotherapy it is possible to accurately predict how the tumor is responding to treatment.

Quing-zhu
Breast-cancer-research
School-of-medicine
Office-of-technology-management
Mckelvey-school-of-engineering
Washington-university-school-of-medicine
Washington-university-in-st
Washington-university
Washington-university-school
Barnes-jewish-hospital
Treatment-may
Mckelvey-school

Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer

/PRNewswire/ Sanofi is partnering with leading groups delivering practice-changing breast cancer research, the Breast International Group (BIG), the.

United-states
Paris
France-general
France
Brussels
Bruxelles-capitale
Belgium
Eva-schaefer-jansen
Arnaud-delepine
Suzanne-greco
Felix-lauscher
Prnewswire-sanofi

Novartis Pharma AG: Novartis 177Lu-PSMA-617 significantly improves overall survival and radiographic progression-free survival for men with metastatic castration-resistant prostate cancer in Phase III VISION study

Novartis Pharma AG: Novartis 177Lu-PSMA-617 significantly improves overall survival and radiographic progression-free survival for men with metastatic castration-resistant prostate cancer in Phase III VISION study 177 Lu-PSMA-617 plus best standard of care had a 38% reduction in risk of death (median OS benefit of 4 months) and a 60% reduction in the risk of radiographic disease progression or death (median rPFS benefit of 5 months) compared to best standard of care alone 1 Significant improvement demonstrated in all key secondary endpoints, including time to first symptomatic skeletal event, overall response rate and disease control rate 1 VISION study findings to be presented during 2021 ASCO plenary; regulatory submissions to US and EU Health Authorities on track for 2H21; two additional pivotal studies in earlier lines of treatment for metastatic prostate cancer to start 1H21, goal to move into earlier stages of disease

United-states
America
Isabella-zinck
Samir-shah
Julie-masow
Thomas-hungerbuehler
Sloan-simpson
Rachel-levine
Exchange-commission
Eu-health-authorities
Twitter
Novartis-company